Zobrazeno 1 - 10
of 79
pro vyhledávání: '"S. J. Harland"'
Autor:
Daniel M. Berney, Jonathan Shamash, T. Oliver, Anju Sahdev, S. J. Harland, Andrew Gogbashian, Constantine Alifrangis, Gordon J. S. Rustin, Samita Agarwal, Marina Milic, Sarah Duncan, Sara Stoneham, Shafi Chowdhury, Anand Sharma, Michelle Lockley, Peter Wilson
Publikováno v:
European Journal of Cancer. 164:105-113
Background Radiotherapy and cisplatin-based combination chemotherapy are accepted standard-of-care treatments for metastatic seminoma with excellent survival outcomes but with established short- and long-term morbidity. Carboplatin monotherapy may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd350631e3654266f8480a5e81c1b74
https://doi.org/10.1016/j.ejca.2020.08.031
https://doi.org/10.1016/j.ejca.2020.08.031
Autor:
Jeff White, Peter Wilson, Danish Mazhar, Robert Huddart, S. J. Harland, A. Birtle, Sarah Vinnicombe, Shah-Jalal Sarker, Kashfia Chowdhury, Johnathan Joffe, M.R. Marshall, Jonathan Shamash
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 28(6)
Background Bleomycin is an integral part of combination chemotherapy in germ cell tumours. Pulmonary toxicity often necessitates drug cessation and death occurs in 1%–2% of patients. A continuous infusion of bleomycin might reduce lung toxicity whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16fa5000437ef67a199d2110d5bbf07
https://pubmed.ncbi.nlm.nih.gov/28327896
https://pubmed.ncbi.nlm.nih.gov/28327896
Autor:
S. J. Harland
Publikováno v:
Trends in Urology & Men's Health. 4:33-36
Stephen Harland recounts the story of his encounter with the General Medical Council, and outlines the lessons learned. Copyright © 2013 John Wiley & Sons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2efc92f8482317c24a4cbb50a9c9f984
https://doi.org/10.1002/tre.367
https://doi.org/10.1002/tre.367
Autor:
T. Oliver, Jonathan Shamash, Laura Tookman, Thomas Powles, Sukaina Rashid, Mariam Jamal-Hanjani, Melissa Phillips, Athena Matakidou, S. J. Harland, Naveed Sarwar, Peter Wilson, Simon Chowdhury, Wendy Ansell
Publikováno v:
Acta Oncologica. 52:987-993
Objective. Metastatic seminoma is a highly curable disease. Standard treatment comprises of combination chemotherapy. The short- and long-term toxicities of this treatment are increasingly recognised and the possibility of over treatment in such a cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5591b9010d996b1e500abb751724fb98
https://doi.org/10.3109/0284186x.2012.714078
https://doi.org/10.3109/0284186x.2012.714078
Autor:
K. M. Grigor, Gareth Griffiths, Roger Kockelbergh, D.M.A. Wallace, Howard Kynaston, T. Barlow, Mahesh K. B. Parmar, C. Beacock, S. J. Harland, S. Clawson
Publikováno v:
Journal of Urology. 178:807-813
We conducted a multicenter randomized trial in the United Kingdom to determine the efficacy of radical radiotherapy in reducing the incidence of progression of pT1G3 transitional cell carcinoma of the bladder to muscle invasive disease and subsequent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89290bc10b67f6fea385b254f7ac186
https://doi.org/10.1016/j.juro.2007.05.024
https://doi.org/10.1016/j.juro.2007.05.024
The human bladder is very permeable to water. We assessed this work in the context of possible changes in patients with bladder tumours
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::835ca0cde3ec0b1b1675fdb4513f8f04
https://doi.org/10.1159/000418147
https://doi.org/10.1159/000418147
Autor:
John Graham, Graham M. Mead, P. A. Cook, M. Sokal, David P. Dearnaley, J. T. Roberts, Michael Cullen, Stan B. Kaye, Sophie D. Fosså, M. V. Williams, SP Stenning, S. J. Harland
Publikováno v:
British Journal of Cancer
Adjuvant BEP (bleomycin, etoposide, cisplatin) is effective treatment for high-risk clinical stage I (HRCS1) non-seminomatous germ cell tumours (NSGCT), but the known toxicities of etoposide, and the expansion of the HR group to any patient with vasc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b784280b955bd22362ba60d5125b14
https://doi.org/10.1038/sj.bjc.6602624
https://doi.org/10.1038/sj.bjc.6602624
Publikováno v:
British Journal of Cancer
The aim of this study was to examine the efficacy and toxicity of the epirubicin, carboplatin and 5-fluorouracil (ECarboF) regime in patients aged 70 or less with metastatic prostate cancer resistant to LHRH analogues. The majority of patients had pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2620b19fa2dd5683c31838329e8c5db6
http://europepmc.org/articles/PMC2410017
http://europepmc.org/articles/PMC2410017
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
Autor:
G. J. S. Rustin, Iain A. McNeish, Michael J. Seckl, D Driver, C Giles, R Haynes, Edward Kanfer, S J Harland, E. S. Newlands
Publikováno v:
British Journal of Cancer
High-dose regimes containing etoposide, carboplatin and an oxazaphospharine can salvage 30-40% of patients with relapsed or refractory male germ cell tumours (GCTs). The additional benefit of paclitaxel in such high-dose therapy has not been tested.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebcf11244f27d03b1059c8e61868014e
https://doi.org/10.1038/sj.bjc.6601664
https://doi.org/10.1038/sj.bjc.6601664
Publikováno v:
Cancer. 98:2362-2367
BACKGROUND Although < 1% of men present with prostate-specific antigen (PSA)-negative prostate carcinoma, in that they have serum PSA levels much lower than the tumor burden would suggest, such patients represent a management dilemma. To the authors'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9ec051af4be471532d28dcc28d68ec
https://doi.org/10.1002/cncr.11821
https://doi.org/10.1002/cncr.11821